Charlestonpharma

Developing anti-nucleolin antibodies for broad-spectrum cancer therapy

placeCharleston, South Carolina, United States calendar_todayFounded 2010 language charlestonpharma.com

Innovation

2 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 149 times.

YearFilings
20172
20181
20191
20221

Investor mix

3 investors on record; lead investors include Sears Capital Management, SCRA.

Investor typeCountShare
Venture capital267%
Accelerator & incubator133%
Coming soon